Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 16
1996 6
1997 16
1998 103
2000 8
2001 11
2002 22
2003 80
2004 82
2005 91
2006 82
2007 90
2008 77
2009 92
2010 89
2011 83
2012 109
2013 115
2014 96
2015 99
2016 109
2017 117
2018 128
2019 136
2020 132
2021 126
2022 125
2023 112
2024 88
2025 99
2026 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,515 results

Results by year

Filters applied: . Clear all
Page 1
Foreword.
Mínguez B, Lledó-Navarro JL. Mínguez B, et al. Clin Drug Investig. 2022 Jun;42(Suppl 1):1-2. doi: 10.1007/s40261-022-01148-4. Epub 2022 May 9. Clin Drug Investig. 2022. PMID: 35532834 Free PMC article. No abstract available.
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.
Arriola E, de Castro J, García-Campelo R, Bernárdez B, Bernabé R, Bruna J, Dómine M, Isla D, Juan-Vidal Ó, López-Fernández T, Nadal E, Rodríguez-Abreu D, Vares M, Asensio Ú, García LF, Felip E. Arriola E, et al. Clin Drug Investig. 2024 Aug;44(8):553-576. doi: 10.1007/s40261-024-01379-7. Epub 2024 Jul 31. Clin Drug Investig. 2024. PMID: 39085682 Free PMC article. Review.
Foreword.
Maleti O. Maleti O. Clin Drug Investig. 2023 Jun;43(Suppl 1):1-2. doi: 10.1007/s40261-023-01262-x. Epub 2023 May 12. Clin Drug Investig. 2023. PMID: 37173529 Free PMC article. No abstract available.
AVT02: An Adalimumab Biosimilar.
Kang C. Kang C. Clin Drug Investig. 2022 Oct;42(10):875-878. doi: 10.1007/s40261-022-01196-w. Epub 2022 Oct 1. Clin Drug Investig. 2022. PMID: 36181655 Free PMC article. Review.
PB006: A Natalizumab Biosimilar.
Shirley M. Shirley M. Clin Drug Investig. 2024 May;44(5):367-370. doi: 10.1007/s40261-024-01360-4. Epub 2024 Apr 29. Clin Drug Investig. 2024. PMID: 38683493 Free PMC article. Review.
AVT04: An Ustekinumab Biosimilar.
Blair HA. Blair HA. Clin Drug Investig. 2024 Jul;44(7):549-552. doi: 10.1007/s40261-024-01375-x. Epub 2024 Jul 4. Clin Drug Investig. 2024. PMID: 38963659 Free PMC article. Review.
FKB238: A Bevacizumab Biosimilar.
Syed YY. Syed YY. Clin Drug Investig. 2021 Sep;41(9):825-828. doi: 10.1007/s40261-021-01065-y. Epub 2021 Aug 4. Clin Drug Investig. 2021. PMID: 34347284 Review.
2,515 results